Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor

Thrombosis Research

Volumn 119, Issue 5, 2007, Pages 601-607

  Barre, D E ^a  

^a CAPE BRETON UNIVERSITY   (Canada)

Author keywords

Apolipoprotein (a); GPIIb IIIa antagonism; Human; Lipoprotein (a); Platelet

Indexed keywords

ADENOSINE DIPHOSPHATE; AMINO ACID; APOLIPOPROTEIN A; ARGINYL GLYCYL ASPARTYL; COLLAGEN; EPITOPE; FIBRINOGEN; FIBRINOGEN RECEPTOR; IODINE 125; LECTIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PAC 1; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN ISOLATION; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ULTRACENTRIFUGATION;

APOPROTEIN(A); BINDING, COMPETITIVE; EPITOPES; HUMANS; OLIGOPEPTIDES; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN BINDING; PROTEIN SUBUNITS;

EID: 33847201430     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.04.013     Document Type: Article

References (48)

1. Mbewu A.D., and Durrington P.N. Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 85 (1990) 1-14
2. Dujurovic S., and Berg K. Epidemiology of lipoprotein (a): its role in atherosclerotic/thrombotic disease. Clin Genet 52 (1997) 281-292
3. Danesh J., Collins R., and Peto R. Lipoprotein (a) and coronary heart disease. Meta analysis of prospective studies. Circulation 102 (2000) 1082-1085
4. Schalich M.P., John S., Langenfeld M.R.W., Lackner K.J., Schmitz G., and Schmieder R.E. Does lipoprotein (a) impair endothelial function?. J Am Coll Cardiol 31 (1998) 359-365
5. Dahlen G.H., and Stenlund H. Lp (a) lipoprotein is a major risk factor for cardiovascular disease. Clin Genet 52 (1997) 272-280
6. Cheng S.W.K., Ting A.C.W., and Wong J. Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular. Eur J Vasc Endovasc Surg 14 (1997) 17-23
7. Miles L.A., and Plow E.F. Lp (a): an interloper into the fibrinolytic system. Thromb Haemost 63 (1990) 331-335
8. Franchesini G., Cofrancesco E., Safa O., Boschetti C., Tremoli E., Mussoni L., et al. Association of lipoprotein (a) with atherothrombotic events and fibrinolytic variables. A case-control study. Thromb Res 78 (1995) 227-238
9. Scanu AM. Lipoprotein (a): its inheritance and molecular basis of its atherothrombotic role. Mol Cell Biochem 113 (1992) 127-131
10. Dahlen G.H. Lipoprotein (a), atherosclerosis and thrombosis. Prog Lipid Res 30 (1991) 189-194
11. Eaton D.L., Fless G.M., Kohr W.J., McLean J.W., Xu Q.-.T., Millar C.J., et al. Partial amino acid sequence of apolipoprotein (a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA 84 (1987) 3224-3228
12. McLean J.W., Tomlinson J.E., Kuang W.-.J., Eaton D.L., Chen E.Y., Fless G.M., et al. cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 330 (1987) 132-137
13. Loscazlo J., Weinfeld M., Fless G.M., and Scanu A.M. Lipoprotein (a), fibrin binding and plasminogen activation. Arteriosclerosis 10 (1990) 240-245
14. Edelberg J.M., and Pizzo S.V. Lipoprotein (a) inhibits plasminogen activation in a template-dependent manner. Blood Coagul Fibrinolysis 2 (1991) 759-764
15. Milionis H., Mikhailidis D.P., and Winder A.F. Platelets and lipoprotein (a): a brief overview of their role in the pathogenesis of atherothrombosis. Platelets 10 (1999) 277-284
16. Mao S.J.T., and Tucci M.A. Lipoprotein (a) enhances plasma clot lysis in vitro. FEBS Lett 267 (1990) 131-134
17. Testa R., and Marcovina S.M. The rate of plasmin formation after in vitro clotting is inversely related to lipoprotein (a) levels. Int J Clin Lab Res 29 (1999) 128-132
18. Collen D., Stump D.C., and Gold H.K. Thrombolytic therapy. Annu Rev Med 39 (1988) 405-423
19. V.J. Marder, W.R. Bell, Fibrinolytic therapy. In Haemostasis and thrombosis. Basic principles and clinical practice. Ed by R.W. Colman, J. Hirsh, V.J. Marder, E.W. Salzman, 2nd edition, 1393-1437.
20. Miller J.L., Katz A.J., and Feinstein M.B. Plasmin inhibition of thrombin-induced platelet aggregation. Thromb Diath Hemorrh 33 (1975) 286-309
21. Huby T., Chapman J., and Thillet J. Pathophysiological implication of the structural domains of lipoprotein (a). Atherosclerosis 133 (1997) 1-6
22. Guevara J., Knapp R.D., Honda S., Northup S.R., and Morrisett J.D. A structural assessment of the apo (a) protein of human lipoprotein (a). Proteins 12 (1992) 188-199
23. Hajjar K.A., and Nachman R.L. The role of lipoprotein (a) in atherogenesis and thrombosis. Annu Rev Med 47 (1996) 423-442
24. Karmansky I., and Gruener N. Structure and possible biological roles of Lp (a). Clin Biochem 27 (1994) 151-162
25. Barre D.E. Lipoprotein (a) reduces platelet aggregation via apo (a)-mediated decreases in thromboxane A2 production. Platelets 9 (1998) 93-96
26. Gries A., Gries M., Wurm H., Kenner T., Ijsseldijk M., Sixma J.J., et al. Lipoprotein (a) inhibits collagen-induced aggregation of thrombocytes. Arterioscler Thromb Vasc Biol 16 (1996) 648-655
27. Barre D.E. Apolipoprotein (a) mediates the lipoprotein (a)-induced biphasic shift in human platelet cyclic AMP. Thromb Res 112 (2003) 321-324
28. Gaubatz J.W., Hiedernan C., Goto Jr. A.M., Morrisett J.D., and Dahlen G.H. Human plasma lipoprotein [a] structural properties. J Biol Chem 258 (1983) 4582-4589
29. Gaubatz J.W., Chari M.V., Nava M.L., Guyton J.R., and Morrisett J.D. Isolation and characterization of the two major apoproteins in human lipoprotein [a]. J Lipid Res 28 (1987) 69-79
30. Fless G.M., ZumMallen M.E., and Scanu A.M. Physico-chemical properties of apolipoprotein (a) and lipoprotein (a)-derived from the dissociation of human plasma lipoprotein (a). J Biol Chem 261 (1986) 8712-8718
31. Kratzin H., Armstrong V.W., Niehaus M., Hilschmann N., and Seidel D. Structural relationship of an apolipoprotein (a) phenotype (570 kDs) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. Biol Chem Hoppes-Seyler 368 (1987) 1533-1544
32. Malle E., Ibovnik A., Steinmetz A., Kostner G.M., and Sattler W. Identification of glycoprotein IIb as the lipoprotein (a)-binding protein on platelets. Lipoprotein (a) binding is independent of an arginyl-glycyl-asparate tripeptide located in apolipoprotein (a). Arterioscler Thromb 14 (1994) 345-352
33. Barre D.E. Apolipoprotein (a) antagonises the GP IIb/IIIa receptor on collagen- and ADP stimulated platelets. Front Biosci 9 (2004) 404-410
34. 1 integrin and GP VI. J Biol Chem 274 (1999) 11897-11903
35. Shattil S.J., Hoxie J.A., Cunningham M., and Brass L.F. Changes in platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem 260 (1985) 11107-11114
36. Shattil S.J. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies. Blood 70 (1987) 307-315
37. Seman L.J., de Luca C., and Jenner J.L. Isolation and purification of serum lipoprotein (a) using lectin affinity. Methods Mol Biol 110 (1998) 131-136
38. Armstrong V.W., Wall A.K., and Seidel D. Isolation, characterization and uptake of human fibroblasts and of apo (a)-free lipoprotein obtained on reduction of Lp (a). J Lipid Res 26 (1985) 1314-1323
39. Sinn H.J., Schrenk H.H., Friedrich E.A., Via D.P., and Dresel H.A. Radioiodination of proteins and lipoproteins using n-bromosuccinamide as oxidizing agents. Anal Biochem 170 (1988) 186-192
40. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.L. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
41. Utermann G., Menzel H.J., Kraft H.G., Dube H.C., Kemmler H.G., and Seitz C. Lp (a) glycoprotein phenotypes. Inheritance and relation to Lp (a)-lipoprotein concentrations in plasma. J Clin Invest 80 (1987) 458-465
42. Aster R.H., and Jandl J.H. Platelet sequestration in man. I. Methods. J Clin Invest 43 (1964) 843-855
43. Mustard J.F., Perry D.W., Ardlie N.G., and Packham M.A. Preparation of suspensions of washed platelets from humans. Br J Haematol 22 (1972) 193-204
44. Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194 (1962) 927-930
45. Taub R., Gould R.J., Garsky V.M., Ciccarone T.M., Hoxie J., Friedman P.A., et al. A monoclonal antibody against the platelet fibrinogen receptor contains a sequence that mimics a receptor recognition domain in fibrinogen. J Biol Chem 264 (1989) 259-265
46. IIbβ3. J Biol Chem 271 (1996) 2033-2039
47. 3. J Biol Chem 274 (1999) 4633-4639
48. Erzatty A., Simon D.I., and Loscalzo J. Lipoprotein (a) binds to human platelets and attenuates plasminogen binding and activation. Biochemistry 32 (1993) 4628-4633